يعرض 1 - 10 نتائج من 25 نتيجة بحث عن '"Guingane, Alice Nanelin"', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
  4. 4
    دورية أكاديمية
  5. 5
  6. 6
    دورية أكاديمية

    المساهمون: University of Cape Town, University of Oxford, Stellenbosch University, LiveWell Initiative Lagos, University of Jos Nigeria, Saint Paul Hospital Millennium Medical College, Ethiopia, Centre hospitalier universitaire de Bodogodo Ouagadougou, Burkina Faso (CHU-B), Vestfold Hospital Tønsberg, Norway, National Organisation for People Living With Hepatitis B Kampala, Imperial College London, London School of Hygiene and Tropical Medicine Fajara, Gambia, London School of Hygiene and Tropical Medicine (LSHTM), The Francis Crick Institute London, University College of London London (UCL), University College London Hospitals (UCLH), Liverpool School of Tropical Medicine (LSTM), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Université Paris Cité (UPCité)-Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Paris Cité (UPCité)-Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Centre Hospitalier Universitaire Yalgado Ouédraogo Ouagadougou, Burkina Faso (CHUYO), Université Joseph Ki-Zerbo Université de Ouagadougou, Burkina Faso (UJZK), Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW), Liverpool School of Tropical Medicine (LSTM)-University of Liverpool-Wellcome Trust-University of Malawi, University of Liverpool, Tygerberg Academic Hospital, University of Alabama at Birmingham Birmingham (UAB), Centre for Research in Infectious Diseases Yaoundé (CRID), University of Zambia Lusaka (UNZA), Universität Bern / University of Bern (UNIBE), BB received funding from GILEAD Sciences for the Women Hepatitis Champions Training in Mauritius, Nigeria, and Egypt. HEPSANET (Hepatitis B in Africa Collaborative Network: https://www.hepsanet.orgTest) was funded by the European Association for the Study of the Liver (EASL) and John C Martin Foundation. KK has received funding from GILEAD Sciences for NOPLHB. ML has received funding from MRC UKRI. PCM receives funding from the Wellcome Trust (ref 110110/Z/15/Z), The Francis Crick Institute, and the UCL NIHR Biomedical Research Centre. PCM receives funding for a PhD student from GSK and this is outside the the scope of this work. GN has received funding from GILEAD Sciences for research. AJS is funded by a National Institute for Health and Care Research (UK) Senior Clinical Lectureship at the University of Liverpool. YS receives research funding from GILEAD Sciences and research materials from Abbott and Fujirebio Inc. MJV holds a grant from the U.S. National Institutes of Health (grant number, R01AI147727). GW is supported by a Professorship grant from the Swiss National Science Foundation, PP00P3_211025. GW has received unrestricted research grants from Gilead Sciences and Roche Diagnostics.

    المصدر: ISSN: 2731-913X ; BMC Global and Public Health ; https://pasteur.hal.science/pasteur-04363871Test ; BMC Global and Public Health, 2023, 1 (1), pp.24. ⟨10.1186/S44263-023-00026-1⟩.

  7. 7
    دورية أكاديمية

    المصدر: BMC Global and Public Health, Vol 1, Issue 1, e24.

    وصف الملف: text

    العلاقة: https://archive.lstmed.ac.uk/23412/1/44263_2023_Article_26.pdfTest; Spearman, C. Wendy, Andersson, Monique I., Bright, Bisi, Davwar, Pantong M., Desalegn, Hailemichael, Guingane, Alice Nanelin, Johannessen, Asgeir, Kabagambe, Kenneth, Lemoine, Maud, Matthews, Philippa C., Ndow, Gibril, Riches, Nicholas, Shimakawa, Yusuke, Sombié, Roger, Stockdale, Alexander J., Taljaard, Jantjie J., Vinikoor, Michael J., Wandeler, Gilles, Okeke, Edith and Sonderup, Mark (2023) 'A new approach to prevent, diagnose, and treat hepatitis B in Africa'. BMC Global and Public Health, Vol 1, Issue 1, e24.

  8. 8
    دورية أكاديمية

    المساهمون: University of Cape Town, University of Oxford, Stellenbosch University, LiveWell Initiative Lagos, University of Jos Nigeria, Saint Paul Hospital Millennium Medical College, Ethiopia, Centre hospitalier universitaire de Bodogodo Ouagadougou, Burkina Faso (CHU-B), Vestfold Hospital Tønsberg, Norway, National Organisation for People Living With Hepatitis B Kampala, Imperial College London, London School of Hygiene and Tropical Medicine Fajara, Gambia, London School of Hygiene and Tropical Medicine (LSHTM), The Francis Crick Institute London, University College of London London (UCL), University College London Hospitals (UCLH), Liverpool School of Tropical Medicine (LSTM), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Université Paris Cité (UPCité)-Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Paris Cité (UPCité)-Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Centre Hospitalier Universitaire Yalgado Ouédraogo (CHUYO), Université Joseph Ki-Zerbo Université de Ouagadougou, Burkina Faso (UJZK), Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW), Liverpool School of Tropical Medicine (LSTM)-University of Liverpool-Wellcome Trust-University of Malawi, University of Liverpool, Tygerberg Academic Hospital, University of Alabama at Birmingham Birmingham (UAB), Centre for Research in Infectious Diseases Yaoundé (CRID), University of Zambia Lusaka (UNZA), Universität Bern / University of Bern (UNIBE), BB received funding from GILEAD Sciences for the Women Hepatitis Champions Training in Mauritius, Nigeria, and Egypt. HEPSANET (Hepatitis B in Africa Collaborative Network: https://www.hepsanet.orgTest) was funded by the European Association for the Study of the Liver (EASL) and John C Martin Foundation. KK has received funding from GILEAD Sciences for NOPLHB. ML has received funding from MRC UKRI. PCM receives funding from the Wellcome Trust (ref 110110/Z/15/Z), The Francis Crick Institute, and the UCL NIHR Biomedical Research Centre. PCM receives funding for a PhD student from GSK and this is outside the the scope of this work. GN has received funding from GILEAD Sciences for research. AJS is funded by a National Institute for Health and Care Research (UK) Senior Clinical Lectureship at the University of Liverpool. YS receives research funding from GILEAD Sciences and research materials from Abbott and Fujirebio Inc. MJV holds a grant from the U.S. National Institutes of Health (grant number, R01AI147727). GW is supported by a Professorship grant from the Swiss National Science Foundation, PP00P3_211025. GW has received unrestricted research grants from Gilead Sciences and Roche Diagnostics.

    المصدر: ISSN: 2731-913X ; BMC Global and Public Health ; https://pasteur.hal.science/pasteur-04363871Test ; BMC Global and Public Health, 2023, 1 (1), pp.24. ⟨10.1186/S44263-023-00026-1⟩.

  9. 9
    دورية أكاديمية

    المساهمون: University of Cape Town, University of Oxford, Stellenbosch University, LiveWell Initiative Lagos, University of Jos Nigeria, Saint Paul Hospital Millennium Medical College, Ethiopia, Centre Hospitalier Universitaire de Bogodogo Ouagadougou, Burkina Faso (CHUB), Vestfold Hospital Tønsberg, Norway, National Organisation for People Living With Hepatitis B Kampala, Imperial College London, London School of Hygiene and Tropical Medicine Fajara, Gambia, London School of Hygiene and Tropical Medicine (LSHTM), The Francis Crick Institute London, University College of London London (UCL), University College London Hospitals (UCLH), Liverpool School of Tropical Medicine (LSTM), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Université Paris Cité (UPCité)-Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Paris Cité (UPCité)-Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Centre Hospitalier Universitaire Yalgado Ouédraogo (CHUYO), Université Joseph Ki-Zerbo Ouagadougou (UJZK), Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW), Liverpool School of Tropical Medicine (LSTM)-University of Liverpool-Wellcome Trust-University of Malawi, University of Liverpool, Tygerberg Academic Hospital, University of Alabama at Birmingham Birmingham (UAB), Centre for Research in Infectious Diseases Yaoundé (CRID), University of Zambia Lusaka (UNZA), Universität Bern / University of Bern (UNIBE), BB received funding from GILEAD Sciences for the Women Hepatitis Champions Training in Mauritius, Nigeria, and Egypt. HEPSANET (Hepatitis B in Africa Collaborative Network: https://www.hepsanet.orgTest) was funded by the European Association for the Study of the Liver (EASL) and John C Martin Foundation. KK has received funding from GILEAD Sciences for NOPLHB. ML has received funding from MRC UKRI. PCM receives funding from the Wellcome Trust (ref 110110/Z/15/Z), The Francis Crick Institute, and the UCL NIHR Biomedical Research Centre. PCM receives funding for a PhD student from GSK and this is outside the the scope of this work. GN has received funding from GILEAD Sciences for research. AJS is funded by a National Institute for Health and Care Research (UK) Senior Clinical Lectureship at the University of Liverpool. YS receives research funding from GILEAD Sciences and research materials from Abbott and Fujirebio Inc. MJV holds a grant from the U.S. National Institutes of Health (grant number, R01AI147727). GW is supported by a Professorship grant from the Swiss National Science Foundation, PP00P3_211025. GW has received unrestricted research grants from Gilead Sciences and Roche Diagnostics.

    المصدر: ISSN: 2731-913X ; BMC Global and Public Health ; https://pasteur.hal.science/pasteur-04363871Test ; BMC Global and Public Health, 2023, 1 (1), pp.24. ⟨10.1186/S44263-023-00026-1⟩.

  10. 10
    دورية أكاديمية

    المساهمون: University of Cape Town, University of Oxford, Stellenbosch University, LiveWell Initiative Lagos, University of Jos Nigeria, Saint Paul Hospital Millennium Medical College, Ethiopia, Centre Hospitalier Universitaire de Bogodogo Ouagadougou, Burkina Faso (CHUB), Vestfold Hospital Tønsberg, Norway, National Organisation for People Living With Hepatitis B Kampala, Imperial College London, London School of Hygiene and Tropical Medicine Fajara, Gambia, London School of Hygiene and Tropical Medicine (LSHTM), The Francis Crick Institute London, University College of London London (UCL), University College London Hospitals (UCLH), Liverpool School of Tropical Medicine (LSTM), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Université Paris Cité (UPCité)-Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Paris Cité (UPCité)-Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Centre Hospitalier Universitaire Yalgado Ouédraogo (CHUYO), Université Joseph Ki-Zerbo Ouagadougou (UJZK), Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW), Liverpool School of Tropical Medicine (LSTM)-University of Liverpool-Wellcome Trust-University of Malawi, University of Liverpool, Tygerberg Academic Hospital, University of Alabama at Birmingham Birmingham (UAB), Centre for Research in Infectious Diseases Yaoundé (CRID), University of Zambia Lusaka (UNZA), Universität Bern / University of Bern (UNIBE), BB received funding from GILEAD Sciences for the Women Hepatitis Champions Training in Mauritius, Nigeria, and Egypt. HEPSANET (Hepatitis B in Africa Collaborative Network: https://www.hepsanet.orgTest) was funded by the European Association for the Study of the Liver (EASL) and John C Martin Foundation. KK has received funding from GILEAD Sciences for NOPLHB. ML has received funding from MRC UKRI. PCM receives funding from the Wellcome Trust (ref 110110/Z/15/Z), The Francis Crick Institute, and the UCL NIHR Biomedical Research Centre. PCM receives funding for a PhD student from GSK and this is outside the the scope of this work. GN has received funding from GILEAD Sciences for research. AJS is funded by a National Institute for Health and Care Research (UK) Senior Clinical Lectureship at the University of Liverpool. YS receives research funding from GILEAD Sciences and research materials from Abbott and Fujirebio Inc. MJV holds a grant from the U.S. National Institutes of Health (grant number, R01AI147727). GW is supported by a Professorship grant from the Swiss National Science Foundation, PP00P3_211025. GW has received unrestricted research grants from Gilead Sciences and Roche Diagnostics.

    المصدر: ISSN: 2731-913X ; BMC Global and Public Health ; https://pasteur.hal.science/pasteur-04363871Test ; BMC Global and Public Health, 2023, 1 (1), pp.24. ⟨10.1186/S44263-023-00026-1⟩.